Clinical Trial Update: Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low-dose sugammadex with neostigmine and glycopyrrolate for reversal of rocuronium in neuromuscular blockade has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)
• Neostigmine (neostigmine)
• Rocuronium (rocuronium bromide)
• Sugammadex (sugammadex)

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: Neuromuscular Blockade | Phase 4 | Status: COMPLETED